AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 0.82% to $146.40 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.75% to 3,871.98 and Dow Jones Industrial Average falling 0.39% to 32,732.95. This was the stock's second consecutive day of losses. AbbVie Inc. closed $29.51 short of its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Pfizer Inc. (PFE) fell 1.86% to $46.55, Eli Lilly & Co. (LLY) rose 0.61% to $362.09, and AstraZeneca PLC ADR (AZN.LN) rose 0.17% to $58.81. Trading volume (8.5 M) eclipsed its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 31, 2022.
(END) Dow Jones Newswires
October 31, 2022 16:33 ET (20:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.